PRPO logo

Precipio, Inc. Stock Price

NasdaqCM:PRPO Community·US$31.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

PRPO Share Price Performance

US$19.33
13.25 (218.19%)
US$19.33
13.25 (218.19%)
Price US$19.33

PRPO Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet and fair value.

3 Risks
2 Rewards

Precipio, Inc. Key Details

US$21.2m

Revenue

US$11.8m

Cost of Revenue

US$9.5m

Gross Profit

US$11.3m

Other Expenses

-US$1.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 17, 2025
-1.11
44.69%
-8.48%
0.7%
View Full Analysis

About PRPO

Founded
n/a
Employees
57
CEO
Ilan Danieli
WebsiteView website
www.precipiodx.com

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Recent PRPO News & Updates

Precipio, Inc.'s (NASDAQ:PRPO) Shares Leap 28% Yet They're Still Not Telling The Full Story

Sep 08
Precipio, Inc.'s (NASDAQ:PRPO) Shares Leap 28% Yet They're Still Not Telling The Full Story

Recent updates

No updates